[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $hlubf $HLUBF sees a surge in creator activity with positive news from Praxis. Engagements are high, driven by the FDA Breakthrough Therapy Designation. ### About $hlubf A cryptocurrency asset. ### Insights [#](/topic/$hlubf/insights) - $hlubf creators is up XXX% from the previous week. - $hlubf Creators hit a high of X for the day - $hlubf Creators hit an all time of X for the day - $hlubf Engagements hit a high of XXXXX for the day - $hlubf Engagements hit an all time of XXXXX for the day ### Engagements: XXX [#](/topic/$hlubf/interactions) ---  [Engagements 24-Hour Chart Data](/topic/$hlubf/time-series/interactions.tsv) **Current Value**: XXX **Daily Average**: XX **1 Month**: XXXXX +125% **1-Year High**: XXXXX on 2025-07-18 **1-Year Low**: X on 2025-05-01 | Social Network | X | | -------------- | - | | Engagements | XXX | ### Mentions: X [#](/topic/$hlubf/posts_active) ---  [Mentions 24-Hour Chart Data](/topic/$hlubf/time-series/posts_active.tsv) **Current Value**: X **Daily Average**: X **1 Week**: X no change **1 Month**: X +50% **1-Year High**: X on 2025-04-29 **1-Year Low**: X on 2025-05-01 | Social Network | X | | -------------- | - | | Mentions | X | ### Creators: X [#](/topic/$hlubf/contributors_active) ---  [Creators 24-Hour Chart Data](/topic/$hlubf/time-series/contributors_active.tsv) X unique social accounts have posts mentioning $hlubf in the last XX hours which is down XX% from X in the previous XX hours **Daily Average**: X **1 Week**: X +100% **1 Month**: X +100% **1-Year High**: X on 2025-07-18 **1-Year Low**: X on 2025-04-29 **Top assets mentioned** In the posts about $hlubf in the last XX hours [Biogen Inc (BIIB)](/topic/$biib) **Top topics mentioned** In the posts about $hlubf in the last XX hours [$ucbjf](/topic/$ucbjf), [$biib](/topic/$biib), [$aqst](/topic/$aqst), [nyc](/topic/nyc), [investment](/topic/investment), [brt](/topic/brt), [$snnuf](/topic/$snnuf), [$aoiff](/topic/$aoiff), [$olp](/topic/$olp), [$skfof](/topic/$skfof) ### Top Social Posts [#](/topic/$hlubf/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "H.C. Wainwright reitd $PRAX Buy-$105 after Praxis announced that FDA had granted Breakthrough Therapy Designation (BTD) for relutrigine for the treatment of pediatric patients with SCN2A and SCN8A DEEs. $RAPP $XENE $BHVN $DRUG $NBIX ( $LBPH - $HLBBF $HLUBF) H.C. Wainwright said in its note: "While investor attention has largely been on the upcoming readout of vormatrigine's RADIANT study in focal onset seizures there has been increasing appreciation that relutrigine is deserving of attention. There's a case to be made that relutrigine's commercial potential in DEEs may even exceed" [@Quantumup1](/creator/x/Quantumup1) on [X](/post/tweet/1946188742093586828) 2025-07-18 12:42:09 UTC 3519 followers, 1325 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$hlubf
$HLUBF sees a surge in creator activity with positive news from Praxis. Engagements are high, driven by the FDA Breakthrough Therapy Designation.
About $hlubf
A cryptocurrency asset.
Insights #
- $hlubf creators is up XXX% from the previous week.
- $hlubf Creators hit a high of X for the day
- $hlubf Creators hit an all time of X for the day
- $hlubf Engagements hit a high of XXXXX for the day
- $hlubf Engagements hit an all time of XXXXX for the day
Engagements: XXX #
Engagements 24-Hour Chart Data
Current Value: XXX
Daily Average: XX
1 Month: XXXXX +125%
1-Year High: XXXXX on 2025-07-18
1-Year Low: X on 2025-05-01
| Social Network | X |
|---|---|
| Engagements | XXX |
Mentions: X #
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Week: X no change
1 Month: X +50%
1-Year High: X on 2025-04-29
1-Year Low: X on 2025-05-01
| Social Network | X |
|---|---|
| Mentions | X |
Creators: X #
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $hlubf in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: X
1 Week: X +100%
1 Month: X +100%
1-Year High: X on 2025-07-18
1-Year Low: X on 2025-04-29
Top assets mentioned In the posts about $hlubf in the last XX hours
Top topics mentioned In the posts about $hlubf in the last XX hours
$ucbjf, $biib, $aqst, nyc, investment, brt, $snnuf, $aoiff, $olp, $skfof
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"H.C. Wainwright reitd $PRAX Buy-$105 after Praxis announced that FDA had granted Breakthrough Therapy Designation (BTD) for relutrigine for the treatment of pediatric patients with SCN2A and SCN8A DEEs. $RAPP $XENE $BHVN $DRUG $NBIX ( $LBPH - $HLBBF $HLUBF) H.C. Wainwright said in its note: "While investor attention has largely been on the upcoming readout of vormatrigine's RADIANT study in focal onset seizures there has been increasing appreciation that relutrigine is deserving of attention. There's a case to be made that relutrigine's commercial potential in DEEs may even exceed"
@Quantumup1 on X 2025-07-18 12:42:09 UTC 3519 followers, 1325 engagements